BIODESIX INC - 8-K Filing
Biodesix, Inc. announces the departure of Chief Commercial Officer Kieran O’Kane effective November 2, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $BDSX
Read the full article at SEC EDGAR
Part of the story BRADY CORP - 8-K Filing (3 articles)